Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
05 2020
Historique:
received: 23 12 2019
revised: 10 02 2020
accepted: 11 02 2020
pubmed: 15 4 2020
medline: 20 4 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

Defects in ion channels and neurotransmitter receptors are implicated in developmental and epileptic encephalopathy (DEE). Metabotropic glutamate receptor 7 (mGluR7), encoded by GRM7, is a presynaptic G-protein-coupled glutamate receptor critical for synaptic transmission. We previously proposed GRM7 as a candidate disease gene in two families with neurodevelopmental disorders (NDDs). One additional family has been published since. Here, we describe three additional families with GRM7 biallelic variants and deeply characterize the associated clinical neurological and electrophysiological phenotype and molecular data in 11 affected individuals from six unrelated families. Exome sequencing and family-based rare variant analyses on a cohort of 220 consanguineous families with NDDs revealed three families with GRM7 biallelic variants; three additional families were identified through literature search and collaboration with a clinical molecular laboratory. We compared the observed clinical features and variants of 11 affected individuals from the six unrelated families. Identified novel deleterious variants included two homozygous missense variants (c.2671G>A:p.Glu891Lys and c.1973G>A:p.Arg685Gln) and one homozygous stop-gain variant (c.1975C>T:p.Arg659Ter). Developmental delay, neonatal- or infantile-onset epilepsy, and microcephaly were universal. Three individuals had hypothalamic-pituitary-axis dysfunction without pituitary structural abnormality. Neuroimaging showed cerebral atrophy and hypomyelination in a majority of cases. Two siblings demonstrated progressive loss of myelination by 2 years in both and an acquired microcephaly pattern in one. Five individuals died in early or late childhood. Detailed clinical characterization of 11 individuals from six unrelated families demonstrates that rare biallelic GRM7 pathogenic variants can cause DEEs, microcephaly, hypomyelination, and cerebral atrophy.

Identifiants

pubmed: 32286009
doi: 10.1002/acn3.51003
pmc: PMC7261753
doi:

Substances chimiques

Receptors, Metabotropic Glutamate 0
metabotropic glutamate receptor 7 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-627

Subventions

Organisme : NHGRI NIH HHS
ID : U54HG003273
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS105078
Pays : United States
Organisme : NIH HHS
ID : T32 NS043124-17
Pays : United States
Organisme : NIH HHS
ID : T32 GM007526-42
Pays : United States
Organisme : NINDS NIH HHS
ID : R35NS105078
Pays : United States
Organisme : NHGRI NIH HHS
ID : K08 HG008986
Pays : United States

Informations de copyright

© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Am J Hum Genet. 2012 Sep 7;91(3):553-64
pubmed: 22901947
Neurol Genet. 2018 Nov 07;4(6):e281
pubmed: 30533527
Nat Genet. 2011 Dec 04;44(1):78-84
pubmed: 22138692
J Neurosci. 2008 Aug 20;28(34):8604-14
pubmed: 18716219
Neuron. 2008 Jun 12;58(5):736-48
pubmed: 18549785
Life Sci. 2013 Feb 7;92(2):149-53
pubmed: 23201551
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18163-8
pubmed: 17989220
Front Mol Neurosci. 2018 Oct 23;11:387
pubmed: 30405350
Genome Med. 2017 Aug 14;9(1):73
pubmed: 28807008
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Am J Hum Genet. 2017 Dec 7;101(6):1013-1020
pubmed: 29220673
Neuron. 2015 Nov 4;88(3):499-513
pubmed: 26539891
Eur J Neurosci. 1999 Feb;11(2):663-72
pubmed: 10051767
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Lancet Neurol. 2016 Mar;15(3):304-16
pubmed: 26597089
Nat Commun. 2019 Jul 12;10(1):3094
pubmed: 31300657
Trends Pharmacol Sci. 2007 Feb;28(2):75-82
pubmed: 17222465
Nat Commun. 2014 Jul 22;5:4501
pubmed: 25047565
Neural Plast. 2012;2012:728267
pubmed: 22779007
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18712-7
pubmed: 16339898
Genome Med. 2016 Jan 06;8(1):3
pubmed: 26739615
Genet Med. 2018 Dec;20(12):1528-1537
pubmed: 29790871
Annu Rev Pharmacol Toxicol. 1997;37:205-37
pubmed: 9131252
J Comp Neurol. 1995 Oct 2;360(4):555-70
pubmed: 8801249
Mol Pharmacol. 2004 Feb;65(2):370-80
pubmed: 14742679
BMC Med Genomics. 2016 Jul 19;9(1):42
pubmed: 27435318
Brain. 2019 Oct 1;142(10):3009-3027
pubmed: 31504254
Annu Rev Pharmacol Toxicol. 2010;50:295-322
pubmed: 20055706
Hum Mutat. 2019 Nov;40(11):1968-1984
pubmed: 31343797
JAMA Psychiatry. 2017 Mar 1;74(3):293-299
pubmed: 28097321
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:11-7
pubmed: 25661849
Semin Neurol. 2015 Jun;35(3):193-200
pubmed: 26060898
Drugs Today (Barc). 2010 Apr;46(4):265-77
pubmed: 20502724
Curr Neuropharmacol. 2005 Oct;3(4):299-307
pubmed: 18369399
Eur J Hum Genet. 2011 Nov;19(11):1161-6
pubmed: 21629298
J Neurosci. 2001 Nov 15;21(22):8734-45
pubmed: 11698585
Behav Brain Res. 2004 Oct 5;154(2):473-81
pubmed: 15313036
Curr Neuropharmacol. 2016;14(5):504-13
pubmed: 27306064
Cell. 2011 Jun 24;145(7):1036-48
pubmed: 21703448
Acta Neurol Scand Suppl. 2013;(197):19-24
pubmed: 23480152
Neuron. 2013 Oct 16;80(2):292-311
pubmed: 24139035
J Neurosci. 2003 Aug 6;23(18):7069-74
pubmed: 12904467
Behav Brain Res. 2016 Sep 15;311:287-297
pubmed: 27211063
J Neurol Sci. 2006 Aug 15;247(1):1-9
pubmed: 16697014
Am J Hum Genet. 2007 Oct;81(4):792-8
pubmed: 17847003
Nat Neurosci. 2008 Aug;11(8):940-8
pubmed: 18641645
Am J Hum Genet. 2016 Dec 1;99(6):1261-1280
pubmed: 27839871
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
J Hum Genet. 2017 Jun;62(6):589-597
pubmed: 28228639
Physiol Res. 2008;57(6):969-72
pubmed: 19154087
Genet Med. 2017 Jan;19(1):13-19
pubmed: 27171548
Cold Spring Harb Perspect Med. 2015 Jun 22;5(8):a022863
pubmed: 26101204
J Neurosci. 1999 Feb 1;19(3):955-63
pubmed: 9920659
Am J Hum Genet. 2018 Aug 2;103(2):171-187
pubmed: 30032986
PLoS Biol. 2007 Oct;5(10):e269
pubmed: 17927447
Am J Hum Genet. 2017 Mar 2;100(3):555-561
pubmed: 28257693

Auteurs

Dana Marafi (D)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.
Department of Pediatrics, Faculty of Medicine, Kuwait University, P.O. Box 24923, 13110, Safat, Kuwait.

Tadahiro Mitani (T)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Sedat Isikay (S)

Department of Physiotherapy and Rehabilitation, School of Health Sciences, Hasan Kalyoncu University, Gaziantep, 27000, Turkey.

Jozef Hertecant (J)

Pediatric Metabolic and Genetics Division, Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates.

Mohammed Almannai (M)

Section of Medical Genetics, Children's Hospital, King Fahad Medical City, Riyadh, 11525, Saudi Arabia.

Kandamurugu Manickam (K)

Division of Genetic and Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio.

Rami Abou Jamra (R)

Institute of Human Genetics, University Medical Center Leipzig, 04103, Leipzig, Germany.

Ayman W El-Hattab (AW)

Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.

Jaishen Rajah (J)

Sheikh Khalifa Medical City (SKMC), P.O. Box: 51900, Abu Dhabi, United Arab Emirates.

Jawid M Fatih (JM)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Haowei Du (H)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Ender Karaca (E)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Yavuz Bayram (Y)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Jaya Punetha (J)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Jill A Rosenfeld (JA)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Shalini N Jhangiani (SN)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, 77030.

Eric Boerwinkle (E)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, 77030.
Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas.

Zeynep C Akdemir (ZC)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

Serkan Erdin (S)

Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.

Jill V Hunter (JV)

Texas Children's Hospital, Houston, Texas, 77030.
Department of Radiology, Baylor College of Medicine, Houston, Texas, 77030.

Richard A Gibbs (RA)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, 77030.

Davut Pehlivan (D)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.
Texas Children's Hospital, Houston, Texas, 77030.
Section of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, 77030.

Jennifer E Posey (JE)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.

James R Lupski (JR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, 77030.
Texas Children's Hospital, Houston, Texas, 77030.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, 77030.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH